COMPOSITION AND METHOD FOR DIAGNOSING BREAST CANCER USING EXTRACELLULAR VESICLE-MIRNA
Number of patents in Portfolio can not be more than 2000
United States of America
Stats
-
N/A
Issued Date -
Feb 6, 2025
app pub date -
Oct 4, 2023
filing date -
Oct 4, 2023
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
Disclosed are a composition and a method for diagnosing breast cancer using extracellular vesicle-miRNA. The composition for diagnosing the breast cancer according includes an agent that measures an expression level of at least one miRNA selected from a group consisting of miR-9, MiR-16, MiR-21, and MiR-429. Furthermore, the method for diagnosing breast cancer includes measuring an expression level of at least one miRNA selected from a group consisting of MiR-9, MiR-16, MiR-21, and MiR-429 from a sample, and diagnosing the breast cancer based on the measurement result.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully